All Posts

A medical device validation study is only as strong as the protocol guiding it. A well-designed protocol provides clear procedures, prespecified endpoints, consistent study conduct, and a structured framework for generating high-quality clinical data. Clinical trial protocol development is a critical component of successful medical device validation and helps ensure that study results are interpretable, traceable, and regulator-ready. Why Protocol Development Matters The p

Collecting clinical data is only one part of generating regulator-ready evidence. Regulatory reviewers expect clinical datasets that are accurate, traceable, complete, and supported by clearly documented methods and prespecified analysis procedures. Strong data quality practices help sponsors reduce review questions, support efficient regulatory assessment, and ensure study results can be interpreted with confidence. What Is a Regulator-Ready Dataset? A regulator-ready dat

Pulse oximetry validation studies rely on precise reference measurements to determine device accuracy. One of the most important concepts in these studies is understanding the difference between SpO₂ and SaO₂. Although the terms are closely related, they are not interchangeable. What Is SpO₂? SpO₂ refers to oxygen saturation estimated noninvasively by a pulse oximeter. Pulse oximeters use optical sensors and photoplethysmography (PPG) signals to estimate oxygen saturation

Continuous blood pressure monitoring devices generate large volumes of rapidly changing physiological data. In validation studies, even minor timing mismatches between investigational and reference systems can produce misleading accuracy results. Time alignment is therefore one of the most critical factors in continuous blood pressure validation. Blood Pressure Changes Constantly A reference measurement collected even a few seconds earlier or later may not represent the sa

Blood pressure technologies now range from traditional cuff-based monitors to advanced systems that estimate pressure frequently or continuously. While both aim to report systolic and diastolic blood pressure, intermittent and continuous devices are validated differently because their outputs, clinical use cases, and reference pairing needs are fundamentally different. Understanding the validation pathway early helps sponsors select the correct reference method, build the ri

Cuffless blood pressure technologies are transforming physiological monitoring by enabling continuous, wearable, and minimally intrusive measurement approaches. Validating these devices requires careful study design because traditional cuff-based reference techniques do not always match continuous or near-continuous outputs. For continuous non-invasive blood pressure systems, validation expectations are addressed by ISO 81060-3. Selecting the correct reference method is one

Reference measurement quality is foundational to a successful blood pressure validation study because every accuracy result depends on the strength of the reference. In ISO 81060-2 cuff-based validation, dual-observer auscultation is widely used as the reference method to support consistent systolic and diastolic blood pressure determination from Korotkoff sounds. This improves reproducibility across measurement sequences and produces clear, regulator-ready evidence for devic

What is a Blood Pressure Validation Study? Blood pressure devices cannot enter the market based solely on engineering performance or bench testing. Sponsors must demonstrate that device measurements are accurate when compared against validated clinical reference methods. A blood pressure validation study provides the clinical evidence needed to support FDA submissions, CE mark activities, and global regulatory acceptance. For cuff-based non-invasive blood pressure devices,

Blood pressure validation studies depend on a reference method that is clinically grounded and repeatable. For intermittent blood pressure devices, that reference is often manual auscultation, where trained observers use a cuff and stethoscope to determine systolic and diastolic pressure based on Korotkoff sounds. These sounds provide the clinical signal used to identify the points at which blood flow first returns and then becomes silent again as the cuff deflates. For inte

Why IEEE 1708-2025 Matters for Cuffless Blood Pressure Validation Cuffless blood pressure technology is advancing quickly, and credible performance claims depend on well-designed clinical validation studies. Unlike traditional cuff-based monitors, wearable and cuffless devices may use sensors, algorithms, calibration methods, or continuous signal processing to estimate blood pressure. IEEE 1708-2025 establishes an evaluation framework for wearable cuffless blood pressure me

Why ISO 81060-3 Matters for Continuous Blood Pressure Devices Continuous non-invasive blood pressure monitoring is fundamentally different from intermittent cuff readings. Instead of producing a single systolic and diastolic value at discrete time points, continuous systems output frequent blood pressure estimates and trends over time. ISO 81060-3 defines the clinical validation framework for evaluating continuous non-invasive blood pressure devices under standardized condi

Planning a Blood Pressure Validation Study Designing a blood pressure validation study requires careful planning to support reliable measurement comparisons. Early clinical trial protocol development should clearly define the device’s intended use, primary accuracy endpoints, and reference method used for comparison. This up-front structure helps keep study execution, data collection, and reporting consistent from the first participant through the final report. Key Eleme

The Rise of Wearable Blood Pressure Devices Advances in sensor technology and signal processing have accelerated the development of wearable and cuffless blood pressure devices, including systems designed for intermittent spot checks and those that aim to estimate blood pressure more frequently over time. Unlike traditional cuff-based monitors, wearable and cuffless technologies must perform under real-world conditions where movement and posture can influence measurements.

What Is ISO 81060-2? ISO 81060-2 is an international standard that defines how to clinically validate intermittent automated non-invasive blood pressure devices. It establishes the study framework used to determine whether a device’s systolic and diastolic readings align with qualified reference measurements under standardized conditions. Key Components of the Standard Validation studies conducted under ISO 81060-2 typically include: Structured measurement sequences using

The Importance of High-Resolution Reference Measurements Blood pressure validation studies require reference measurements that accurately reflect physiological conditions. While auscultatory measurements provide reliable values, some studies require continuous high-resolution monitoring. In these cases, researchers may use arterial line monitoring. What Is Arterial Line Monitoring? An arterial catheter allows researchers to measure blood pressure directly within an art

Why Reference Measurements Matter Every blood pressure validation study relies on a reliable reference method to evaluate device accuracy. A trusted reference measurement provides the foundation for determining whether a monitoring device delivers accurate and clinically meaningful readings. At Parameters Research Laboratory (PRL), reference measurements are conducted by highly trained clinical research staff with deep experience in physiological monitoring studies. This lev

Blood Pressure Device Validation Studies Accurate blood pressure measurement is fundamental to physiological monitoring. As new technologies expand beyond traditional cuffs into wearable and cuffless blood pressure devices, sponsors must demonstrate performance using a structured blood pressure validation study. These studies evaluate how closely a device’s measurements align with reference measurements obtained through established clinical methods and generate the evidence r

Why Human Factors Matter Accuracy alone does not determine whether a physiological monitoring device performs well in real-world use. Human factors studies evaluate how users interact with a device during normal operation. They confirm that the device can be used correctly and repeatedly under the conditions reflected in its claims. For medical device manufacturers, this work strengthens the evidence package by showing that performance is achievable under realistic workflo

Why Multi-Site Studies Matter Physiological monitoring devices increasingly rely on clinical evidence that reflects real-world use and diverse populations. Some studies may require clinical data to be collected across multiple research locations. Multi-site clinical research studies allow sponsors to expand recruitment and collect larger datasets while maintaining consistent study protocols. When executed under Good Clinical Practice (GCP) and ISO 14155, multi-site program

Why Submission Delays Occur Regulatory submissions for physiological monitoring devices often depend on clinical evidence demonstrating device performance. When study protocols are poorly aligned with regulatory expectations, organizations may encounter FDA submission delays . Common causes include: incomplete clinical datasets inconsistent study protocols inadequate documentation The Role of Clinical Trial Protocol Development A well-structured clinical trial pro